Visteon Announces Second Quarter 2023 Results
03 août 2023 06h55 HE
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today reported second quarter financial results. Highlights include: Sales of $983 million, up 18%1...
Broadwind Announces Second Quarter 2023 Conference Call and Webcast Date
02 août 2023 18h00 HE
|
Broadwind
CICERO, Ill., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced that it...
Lightbridge Provides Business Update and Announces Second Quarter 2023 Financial Results
26 juil. 2023 16h10 HE
|
Lightbridge Corporation
RESTON, Va., July 26, 2023 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the second quarter ended June...
ARCA biopharma Announces Second Quarter 2023 Financial Results
21 juil. 2023 16h25 HE
|
ARCA biopharma, Inc.
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE...
Lightbridge to Hold Business Update & Second Quarter 2023 Earnings Conference Call on Thursday, July 27 at 4 p.m. ET
20 juil. 2023 07h30 HE
|
Lightbridge Corporation
RESTON, Va., July 20, 2023 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, will announce its financial results for the second quarter ended...
Visteon to Announce Second-Quarter 2023 Results on August 3
18 juil. 2023 17h20 HE
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., July 18, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its second-quarter 2023...
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update
19 mai 2023 05h00 HE
|
Alvotech
Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same period in 2022Confirmatory patient study for AVT05, a proposed biosimilar for Simponi® and...
Alvotech birtir uppgjör fyrir fyrstu þrjá mánuði ársins 2023 og kynnir nýjustu áfanga í rekstri félagsins
19 mai 2023 05h00 HE
|
Alvotech
Tekjur á fyrsta fjórðungi ársins jukust samanborið við sama tímabil í fyrra, úr 0,8 milljónum dollara í 15,9 milljónir dollaraFimmta lyf Alvotech hefur verið tekið til klínískra rannsókna á...
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update
19 mai 2023 05h00 HE
|
Alvotech
Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same period in 2022Confirmatory patient study for AVT05, a proposed biosimilar for Simponi®...
CENTOGENE Reports Full Year 2022 Financial Results
16 mai 2023 18h25 HE
|
Centogene NV
Full Year 2022 total revenues with double-digit growth of 12% at €47.5 million, in line with prior guidanceSignificant expansion of gross profit margin from 32% to 42% and ongoing cost control...